NCDC Weekly Epidemiological Report: Issue: Volume 12 No 5: 1st – 7th February 2021

Situation Report
Originally published
View original


Nigeria Launches Antimicrobial Resistance Community of Practice

In 2017, the Honourable Minister of Health appointed the Nigeria Centre for Disease Control (NCDC) as the National Coordinating Secretariat for Antimicrobial Resistance (AMR surveillance and response in Nigeria. Since then, NCDC has continued to work closely with relevant Ministries, Departments and Agencies (MDAs) as well as key stakeholders to develop the Nigeria’s AMR National Action Plan (NAP) using a One Health approach. This led to Nigeria’s enrollment into the Global Antimicrobial Resistance Surveillance System (GLASS), placing us on the global map for providing AMR data.

NCDC has continued to coordinate with other stakeholders on the implementation of activities across five thematic areas of focus. These include AMR education and awareness; Surveillance; Hygiene, Infection Prevention and Control (IPC) and Biosecurity and Antimicrobial Stewardship and Research.

In our efforts to strengthen AMR-related activities in Nigeria, the Federal Ministry through NCDC on February 24th, 2021 launched the National AMR Community of Practice (AMR CoP). The main goal of the AMR CoP is to bring together and share information amongst key partners in AMR (field implementers, researchers and stakeholders) while advocating for a stronger One-Health (OH) approach. We appreciate the participation of the representatives of relevant MDAs, professional bodies, Fleming Fund, World Health Organization, US Centers for Disease Control, Public Health England etc.

For Nigeria to have an effective CoP capable of holistically tackling the menace of AMR, we are working towards adopting the 5-Level OH approach through the following evidence–based measures:

Level 1: Phenotypic screening and surveys by a network of human and animal health laboratories.

Level 2: Genomic surveillance by the reference laboratories.

Level 3: Instituting functional antimicrobial stewardship to ensure rational use of antibiotics in human and animal health.

Level 4: Dissemination of AMR data at local, national and international levels for informed policies to tackle AMR.

Level 5: Promoting public health awareness for rational use of antibiotics.

An important outcome from the meeting was a better understanding and a consensus on the structure of CoP and agreement on the next steps for operationalisation across human-animal-environment health. The meeting also fostered strong collaboration among relevant MDAs and development partners.

The NCDC remains committed to working with other stakeholders in the fight against AMR.